NURS 6521 Women’s and Men’s Health, Infectious Disease, and Hematologic Disorders
Women’s and Men’s Health, Infectious Disease, and Hematologic Disorders
The patient in the case study is a 46-year-old female with a family history of breast cancer. She currently weighs 230lb and has a history of HTN. She reports having hot flushes, night sweats, and genitourinary symptoms for the past month. The identified patient’s health needs include perimenopausal vasomotor symptoms like hot flushes, night sweats, and genitourinary symptoms. The patient is obese, which increases her risk of developing lifestyle diseases like diabetes, dyslipidemia, and various cancers (Ansari et al., 2020). In addition, the patient’s systolic BP is elevated at 150 mmHg, and her history of HTN puts her at risk of complications like stroke, heart failure, and kidney failure. Furthermore, given her history of ASCUS and family history of breast cancer, she has a high risk for cervical and breast cancer.
The recommended treatment regimen for this patient is the combined Hormone replacement therapy (HRT) comprising estrogen and progesterone. HRT is considered the most effective therapy for perimenopausal vasomotor symptoms. Pan et al. (2022) assert that estrogen therapy is the most effective treatment for alleviating hot flashes. Transdermal administration of estrogen is recommended to avoid the hepatic first-pass effect and reduce the risk of venous thromboembolism. Combining estrogen with progestin is recommended to protect the endometrium for women with an intact uterus, which prevents carcinoma and endometrial hyperplasia (Palacios et al., 2019).
The patient education strategy that can be applied to this patient includes providing her with educational materials in her preferred formats. Consequently, I will need to assess her preferred learning strategy, visual, aural, read/write, or kinesthetic (Bhattad & Pacifico, 2022). If the patient’s learning style is visual, I will use charts, graphics, posters, charts, and PowerPoint presentations to provide patient education. If she is a kinesthetic learner, I would use demonstrations.
References
Ansari, S., Haboubi, H., & Haboubi, N. (2020). Adult obesity complications: challenges and clinical impact. Therapeutic advances in endocrinology and metabolism, 11, 2042018820934955. https://doi.org/10.1177/2042018820934955
Bhattad, P. B., & Pacifico, L. (2022). Empowering Patients: Promoting Patient Education and Health Literacy. Cureus, 14(7), e27336. https://doi.org/10.7759/cureus.27336
Palacios, S., Stevenson, J. C., Schaudig, K., Lukasiewicz, M., & Graziottin, A. (2019). Hormone therapy for first-line management of menopausal symptoms: Practical recommendations. Women’s health (London, England), 15, 1745506519864009. https://doi.org/10.1177/1745506519864009
Pan, M., Pan, X., Zhou, J., Wang, J., Qi, Q., & Wang, L. (2022). Update on hormone therapy for the management of postmenopausal women. Bioscience trends, 16(1), 46–57. https://doi.org/10.5582/bst.2021.0141
ORDER A PLAGIARISM-FREE PAPER HERE
Women’s and Men’s Health, Infectious Disease, and Hematologic Disorders
As an advanced practice nurse, you will likely experience patient encounters with complex comorbidities. For example, consider a female patient who is pregnant who also presents with hypertension, diabetes, and has a recent tuberculosis infection. How might the underlying pathophysiology of these conditions affect the pharmacotherapeutics you might recommend to help address your patient’s health needs? What education strategies might you recommend for ensuring positive patient health outcomes?
For this Discussion, you will be assigned a patient case study and will consider how to address the patient’s current drug therapy plans. You will then suggest recommendations on how to revise these drug therapy plans to ensure effective, safe, and quality patient care for positive patient health outcomes.
Resources
Be sure to review the Learning Resources before completing this activity.
Click the weekly resources link to access the resources.
Learning Resources
Required Readings
- Rosenthal, L. D., & Burchum, J. R. (2021). Lehne’s pharmacotherapeutics for advanced practice nurses and physician assistants (2nd ed.) St. Louis, MO: Elsevier.
- Chapter 46, “Anticoagulant and Antiplatelet Drugs” (pp. 364–371)
- Chapter 47, “Drugs for Deficiency Anemias” (pp. 389–396)
- Chapter 50, “Estrogens and Progestins: Basic Pharmacology and Noncontraceptive Applications” (pp. 425–436)
- Chapter 51, “Birth Control” (pp. 437–446)
- Chapter 52, “Androgens” (pp. 447–453)
- Chapter 53, “Male Sexual Dysfunction and Benign Prostatic Hyperplasia” (pp. 454–466)
- Chapter 70, “Basic Principles of Antimicrobial Therapy” (pp. 651–661)
- Chapter 71, “Drugs That Weaken the Bacterial Cell Wall I: Penicillins” (pp. 662–668)
- Chapter 75, “Sulfonamides Antibiotics and Trimethoprim” (pp. 688–694)
- Chapter 76, “Drug Therapy of Urinary Tract Infections” (pp. 695–699)
- Chapter 78, “Miscellaneous Antibacterial Drugs” (pp. 711–714)
- Chapter 79, “Antifungal Agents” (pp. 715–722)
- Chapter 80, “Antiviral Agents I: Drugs for Non-HIV Viral Infections” (pp. 723–743)
- Chapter 82, “Drug Therapy of Sexually Transmitted Diseases” (pp. 763–770)
- Roberts, H., & Hickey, M. (2016). Managing the menopause: An update
- Links to an external site.. Maturitas, 86(2016), 53–58. https://doi.org/10.1016/j.maturitas.2016.01.007
This article provides an update on treatments on Vasomotor symptoms (VMS), genito-urinary syndrome of menopause (GSM), sleep disturbance, sexual dysfunction, and mood disturbance that are common during the menopause transition.
Required Media
Pharmacology and the Immunological Disorders: Improvements in Medication and Drug Administrations
- Nurse Manager, Bette Nunn discusses how technology has improved the practice of administering drugs and created new and improved drug therapies. The importance of using technology as well as a patient’s knowledge of their own drug history is also discussed.
Time Estimate: 8 minutes
- Speed Pharmacology. (2018). Pharmacology – Antibiotics – Cell wall & membrane inhibitors (Made Easy)
- Links to an external site. [Video]. https://www.youtube.com/watch?v=mMk6VWVpRpo&t=504s
Note: This media program is approximately 16 minutes.
- Speed Pharmacology. (2018). Pharmacology – Antibiotics – DNA, RNA, folic acid, protein synthesis inhibitors (Made Easy)
- Links to an external site. [Video]. https://www.youtube.com/watch?v=5HQmvQJWzNY&t=32s
Note: This media program is approximately 16 minutes.
To Prepare:
- Review the Resources for this module and reflect on the different health needs and body systems presented.
- Your Instructor will assign you a complex case study to focus on for this Discussion.
- Links to an external site.
- Consider how you will practice critical decision making for prescribing appropriate drugs and treatment to address the complex patient health needs in the patient case study you selected.
By Day 3 of Week 9
Post a brief description of your patient’s health needs from the patient case study you assigned. Be specific. Then, explain the type of treatment regimen you would recommend for treating your patient, including the choice or pharmacotherapeutics you would recommend and explain why. Be sure to justify your response. Explain a patient education strategy you might recommend for assisting your patient with the management of their health needs. Be specific and provide examples.
You will respond to your colleagues’ posts in Week 10.
Note: For this Discussion, you are required to complete your initial post before you will be able to view and respond to your colleagues’ postings. Begin by clicking on the Reply button to complete your initial post. Remember, once you click on Post Reply, you cannot delete or edit your own posts and you cannot post anonymously. Please check your post carefully before clicking on Post Reply!
By Day 6 of Week 10
Read a selection of your colleagues’ responses from Week 9 and respond to at least two of your colleagues on two different days who were assigned a different patient case study, and provide recommendations for alternative drug treatments to address the patient’s pathophysiology. Be specific and provide examples.
NURS_6521_Week9_Week10_Discussion_Rubric
Criteria | Ratings | Pts | ||||
---|---|---|---|---|---|---|
This criterion is linked to a Learning Outcome Main Posting |
|
50 pts | ||||
This criterion is linked to a Learning Outcome Main Post: Timeliness |
|
10 pts | ||||
This criterion is linked to a Learning Outcome First Response |
|
18 pts | ||||
This criterion is linked to a Learning Outcome Second Response |
|
17 pts | ||||
This criterion is linked to a Learning Outcome Participation |
|
5 pts | ||||
Total Points: 100 |